New hope for Tough-to-Treat blood cancer? early trial tests novel combo
NCT ID NCT01562405
Summary
This early-stage study is testing a new three-drug combination for multiple myeloma that has returned or stopped responding to prior treatments. The main goal is to find the highest safe dose of the new drug, sotatercept, when given with two existing medications. Researchers will also gather initial information on whether this combination can help control the cancer and improve related issues like anemia and bone problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02215, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Massachusetts General Hosptial
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.